FDA resuming normalized operations but will continue to leverage MRAs
Regulatory NewsJoanne S. Eglovitch
Audit/inspectionBiotechnologyChemistry, Manufacturing and Controls (CMC)North AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy